0
Upcoming Allied Market Research
2023
Drugs For Cytomegalovirus by Drug Type

Drugs For Cytomegalovirus by Drug Type (Valganciclovir, Ganciclovir, Cidofovir, Foscarnet), by Application (Stem Cell Transplantation, Organ Transplantation, Congenital Transplantation, Others) by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) : Global Opportunity Analysis and Industry Forecast, 2022-2032 Market

Report Code: A50524
Pages: NA
May 2023 | 30 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 
Cytomegalovirus (CMV) is a herpes virus that can infect people with compromised immune systems. CMV drugs are intended to reduce the amount of virus in the body and prevent the virus from spreading to other parts of the body. For example, ganciclovir is an antiviral drug that interferes with the replication of CMV. It is used to treat CMV retinitis, a type of eye infection caused by CMV, and CMV colitis, an infection of the colon. 
Patients suffering from HIV/AIDS or who had organ transplants or stem cell transplants have a weak immune system  which has raised the demand for the CMV drug. These patients are more vulnerable to infection, and hence the demand for drugs will increase in the near future.
 
Advances in antiviral drug development for cytomegalovirus (CMV) are another major driver of the cytomegalovirus drug market. Significant progress has been made in the development of cytomegalovirus drugs, with the aim to improve the efficacy and safety standards of the drug paving the way for new and improved versions of the drug for the treatment of  cytomegalovirus infectionsAs a result, new and improved drugs for the treatment of cytomegalovirus infections have been introduced, improving patient outcomes and increasing demand for these drugs. The development of new and more effective cytomegalovirus drugs is expected to continue in the coming years, fueling the growth of the cytomegalovirus drug market. Furthermore, pharmaceutical companies' increasing investment in research and development is contributing to the growth of the cytomegalovirus drug market.   
The global organ transplantation market is experiencing growth, leading to increased demand for drugs to treat cytomegalovirus (CMV) infections. Organ transplant recipients have a higher risk of contracting CMV, making these drugs crucial   to maintaining their health. This market growth, combined with advancements in transplantation procedures and increasing organ donation rates, is driving the demand for cytomegalovirus drugs. Furthermore, globally increasing healthcare spending has resulted in greater access and affordability of drugs for the treatment of cytomegalovirus (CMV) infections. With more healthcare resources available, patients can receive the treatments they require to manage their condition, including CMV drugs. As a result, as more patients gain access to these drugs, the demand for them rises. This trend is expected to continue as healthcare spending rises, boosting demand for CMV treatments and the overall market for these drugs. Furthermore, the growing recognition of the importance of preventative healthcare measures is driving up demand for cytomegalovirus drugs. 
 
New product launches to flourish in the market 
In November 2021, the US Food and Drug Administration (FDA) approved the first treatment for cytomegalovirus (CMV), a type of herpes virus that commonly occurs after transplantation procedures. This approval marks a significant advancement in the treatment of cytomegalovirus, which is a common and potentially serious infection that can affect patients who have received an organ transplant. This approval underscores the importance of continued research and development in the field of transplantation medicine and highlights the need for new treatments for serious infections like cytomegalovirus. It is likely to have a significant impact on patient outcomes and may improve the overall success of transplant procedures.  Also, in November 2022,   the European Commission (EC) approved LIVTENCITY (maribavir) for the treatment of adult patients with post-transplant cytomegalovirus (CMV) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies. This approval is an important step forward in the treatment of CMV, which is a common and potentially serious infection that can occur after transplantation procedures.
Segment Overview: 
By Drug Type: The cytomegalovirus drug market is divided into Valganciclovir, Ganciclovir, Cidofovir, and Foscarnet. These are some of the most commonly prescribed medications for the treatment of cytomegalovirus. This medication is used in conjunction with probenecid to treat a specific viral eye infection (CMV retinitis) in people with AIDS.
 
By Application: The cytomegalovirus drugs market is divided into stem   cell transplantation, organ  transplantation,   congenital   transplantation, and others. The drugs used in these segments vary based on the type of transplantation and the severity of the CMV infection. The segmentation helps in identifying the specific needs and demands of each type of transplantation which helps in the development of effective treatments. 
 
By Distribution Channel: The cytomegalovirus drugs market is divided into retail,hospital, and online pharmacies The distribution channel segmentation helps in understanding the preferences of the customers and the reach of the drugs to the end-users. Retail pharmacies provide over-the-counter drugs, while hospital pharmacies cater to the needs of inpatient and outpatient facilities. Online pharmacies provide a convenient option for purchasing drugs from the comfort of one's home.
 
By Region: The Asia Pacific cytomegalovirus drugs market is expected to grow at a high CAGR In the upcoming years, the market for cytomegalovirus (CMV) medications in Asia Pacific is anticipated to expand at a rapid compound annual growth rate (CAGR). This can be attributed to a number of things, including the rising prevalence of CMV infections, the rise in transplantations, and the rising need for cutting-edge, efficient therapies. Additionally, the rapidly expanding healthcare sector and rising investment in R&D activities are anticipated to support market expansion in the Asia Pacific region. Large patient populations in nations like China, India, Japan, and South Korea are anticipated to propel market expansion in the Asia Pacific region. The availability of cutting-edge treatments and rising public awareness of CMV infections are additional factors anticipated to fuel market expansion. The region's expanding medical tourism sector is anticipated to open up new growth prospects for the CMV drug market.
 
To improve the product portfolio of the cytomegalovirus drugs market, major players such as Chimerix Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton, Dickinson and Company, Pfizer Inc., Merck & Co. Inc., Mylan NV, Johnson & Johnson, Bio-Rad Laboratories, and F. Hoffmann-La Roche AG have used product launch and acquisition as key development strategies.

Drugs For Cytomegalovirus by Drug Type Report Highlights

Aspects Details
By Drug Type
  • Valganciclovir
  • Ganciclovir
  • Cidofovir
  • Foscarnet
By Application
  • Stem Cell Transplantation
  • Organ Transplantation
  • Congenital Transplantation
  • Others
By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players Chimerix Inc, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton, Dickinson and Company, Pfizer Inc., Merck & Co. Inc., Mylan Nv, Johnson & Johnson, Bio-Rad Laboratories, F. Hoffmann-La Roche AG
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Drugs For Cytomegalovirus by Drug Type

Start reading.
This Report and over 19,950+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers